BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23666892)

  • 1. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
    DiStefano JK; Taila M; Alvarez ML
    Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Where are we in diabetic nephropathy: microRNAs and biomarkers?
    McClelland A; Hagiwara S; Kantharidis P
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):80-6. PubMed ID: 24247820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression.
    Mafi A; Aghadavod E; Mirhosseini N; Mobini M; Asemi Z
    J Cell Physiol; 2018 Jan; 234(1):42-50. PubMed ID: 30078212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic nephropathy: The regulatory interplay between epigenetics and microRNAs.
    Sankrityayan H; Kulkarni YA; Gaikwad AB
    Pharmacol Res; 2019 Mar; 141():574-585. PubMed ID: 30695734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.
    Kato M; Natarajan R
    Ann N Y Acad Sci; 2015 Sep; 1353(1):72-88. PubMed ID: 25877817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy.
    Mafi A; Yadegar N; Salami M; Salami R; Vakili O; Aghadavod E
    Pathol Res Pract; 2021 Nov; 227():153618. PubMed ID: 34649056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA: A new generation therapeutic target in diabetic nephropathy.
    Dewanjee S; Bhattacharjee N
    Biochem Pharmacol; 2018 Sep; 155():32-47. PubMed ID: 29940170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
    Kaur P; Kotru S; Singh S; Munshi A
    J Physiol Biochem; 2022 Feb; 78(1):19-37. PubMed ID: 35098434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards microRNA-based therapeutics for diabetic nephropathy.
    Alvarez ML; DiStefano JK
    Diabetologia; 2013 Mar; 56(3):444-56. PubMed ID: 23135222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in diabetic nephropathy: From molecular mechanisms to new therapeutic targets of treatment.
    Yarahmadi A; Shahrokhi SZ; Mostafavi-Pour Z; Azarpira N
    Biochem Pharmacol; 2021 Jul; 189():114301. PubMed ID: 33203517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNAs in Diabetic Kidney Disease.
    Chung AC
    Adv Exp Med Biol; 2015; 888():253-69. PubMed ID: 26663187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNAs in diabetic nephropathy.
    Wu H; Kong L; Zhou S; Cui W; Xu F; Luo M; Li X; Tan Y; Miao L
    J Diabetes Res; 2014; 2014():920134. PubMed ID: 25258717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
    Conserva F; Pontrelli P; Accetturo M; Gesualdo L
    J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of microRNAs in renal disorders related to primary podocyte dysfunction.
    Iranzad R; Motavalli R; Ghassabi A; Pourakbari R; Etemadi J; Yousefi M
    Life Sci; 2021 Jul; 277():119463. PubMed ID: 33862110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.
    Szostak J; GorÄ…cy A; Durys D; Dec P; Modrzejewski A; Pawlik A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT.
    Srivastava SP; Koya D; Kanasaki K
    Biomed Res Int; 2013; 2013():125469. PubMed ID: 24089659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.